Navigation Links
The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
Date:1/29/2013

BURLINGTON, Mass., Jan. 29, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the treatment landscape for hepatocellular carcinoma in the United States and Europe will change dramatically through 2021 as three new, potentially high priced therapies–Novartis's Afinitor, ArQule's tivantinib and Celsion's ThermoDox–arrive on the market, thereby greatly increasing treatment options in patient populations in which there is no approved standard-of-care drug therapy.

According to Niche Markets and Rare Diseases: Hepatocellular Carcinoma, of the forecasted emerging therapies, Afinitor will be the first drug to gain regulatory approval and will launch in 2014 in all markets under study for treatment of advanced hepatocellular carcinoma in the second-line setting following disease progression on Bayer HealthCare/Onyx Pharmaceuticals' Nexavar, the current patient-share leader. By 2021, tivantinib will also launch in the second-line setting for treatment of patients who express high levels of c-MET. ThermoDox, a heat-sensitive liposome-encapsulated formulation of doxorubicin, will be the only therapy to launch over the next ten years in the localized/locally advanced setting for use in combination with radiofrequency embolization (RFA).

"According to opinion leaders, one of the greatest unmet needs in the hepatocellular carcinoma space is for a second-line therapy directed at patients who cannot tolerate treatment with or progress on Nexavar–the standard-of-care in the first-line setting through 2021," said Decision Resources Analyst Karen Pomeranz , Ph.D. "However, the launch of ThermoDox will herald a novel treatment approach in loc
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 02, 2015 Research and ... the "Europe Ultrasound Devices Market - Growth, Trends ... offering. Currently, the European market is dominated ... of France and ... increasing incidences of chronic diseases in these regions. ...
(Date:6/2/2015)... Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... its common stock at a public offering price of ... of 1,764,705 shares to be sold by Nevro and ... stockholders, resulting in aggregate proceeds of approximately $90.0 million ...
(Date:6/2/2015)... 2015  University Hospitals (UH) Case Medical ... area to implant a new miniaturized, wireless monitoring ... is the first and only FDA-approved heart failure monitoring device ... used by physicians to manage heart failure., ... implanted in the pulmonary artery (PA) during a non-surgical procedure ...
Breaking Medicine Technology:European Ultrasound Devices Market Report 2015-2019 2Nevro Announces Pricing of Upsized Public Offering of Common Stock 2Nevro Announces Pricing of Upsized Public Offering of Common Stock 3UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 2UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 3
... to Announce First Quarter Fiscal 2011 Financial Results -- HONG KONG, Sept. 3 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
... Board: ANTXE ) today announced that it had ... to the effect that its Common Stock would be removed ... 2010. The letter indicated that FINRA took ... under the Exchange Act three times in the past two ...
Cached Medicine Technology:China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 2China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 3China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 4China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 5China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 6China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 7AcuNetx Announces Change in Trading Status 2
(Date:6/3/2015)... Unfortunately, a majority of shoes sold are ... comfort to the users throughout the year. Be it a ... the local market, the makers generally tend to put all ... often overlook comfort and health. To counter this problem and ... heads at Vay Technologies have come up with uGALE, an ...
(Date:6/2/2015)... June 03, 2015 BALTIMORE, Md. – ... write a book about wellness after being diagnosed with ... believes that through lifestyle changes which enhance health, lupus ... In “ A Wellspring for Wellness ,” she offers ... , This book provides an overview of some ...
(Date:6/2/2015)... The JK-A0100EU secure smart card keyboard is ... and healthcare. However, this keyboard can also be used ... enhance the security of their network. , The wired ... a Smart Card before allowing access to the connected ... the keyboard supports secure PIN entry. , The keyboard ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Food Lion ... its sixth annual “Thriller on the Griller” events, starting ... and South Carolina locations. Each event will raise funds ... to restoring a sense of self, restoring the family ... our military families. , Through these events, Food ...
(Date:6/2/2015)... On March 19th, 2015, LiveToBeSober.org held an informative ... Legends at Detroit’s Ford Field. Hosted by former Detroit ... goal of the conference was to raise awareness about ... benefits of effective professional rehabilitation programs. It also was ... are available to them in regards to the recent ...
Breaking Medicine News(10 mins):Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 3Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2
... proteins in drug-resistant strains of the Staphylococcus aureus ... blood cellsa key process ensuring that S. aureus ... at the National Institute of Allergy and Infectious ... Health. , S. aureus disease is a global ...
... means intervention may be more effective, researchers say , , ... early rheumatoid arthritis could be identified and enrolled in ... new type of assessment and excluded two traditional assessments, ... looked at 292 people, average age 54, seen at ...
... 6 Month Period, Nasacort AQ Did Not Cause ... Suppression in This Same Age Group, BRIDGEWATER, N.J., ... Allergy, Asthma & Immunology (ACAAI) annual meeting,suggests that the ... used safely and effectively to treat children,aged 2-5 years ...
... Four members of the same,family, who owned ... Equipment,(DME) companies and Comprehensive Outpatient Rehabilitation Facilities have,each ... Medicare fraud, Assistant,Attorney General Alice S. Fisher of ... of the Southern District of Florida announced today., ...
... CHATSWORTH, Calif., Nov. 9 Innovation Management Group,Inc. ... The Magnifier 1.50, a,low cost, full screen magnification ... designed for individuals who have extreme visual,impairments or ... a few hundred to,several thousand dollars. The Magnifier ...
... if used wisely and in the right patients, experts say ... of almost $5 billion to be paid out to those ... the drug,s maker, Merck & Co., may have hoped to ... , But, according to experts, the move has merely swung ...
Cached Medicine News:Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 2Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 3Health News:New Test Criteria Spots Rheumatoid Arthritis Sooner 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 3Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 4Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 5Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 6Health News:Four Miami Health Care Company Owners Sentenced to 57 Months in Prison For Medicare Fraud 2Health News:IMG Announces an Affordable Full Screen Software Magnifier for Home and Business Users 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 3Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 4
... The AutoPulse Resuscitation System consists of ... compression assembly and a rechargeable battery pack ... LifeBand is designed for adults with weight ... of 29.9 to 51.2 inches (76 to ...
... single information technology platform, the VERICIS ... from different sites (office, clinic, hospital) ... x-ray angiography, echo, nuclear, MR, hemodynamics, ... digital record on the cardiac patient. ...
... a pocket sized bidirectional Doppler, designed for use ... and extra long cable (6 feet) are detachable ... placed outside of the sterile field, to maintain ... Doppler's features include red and green LED's in ...
... The CVS4 Complete Vascular System combines cutting edge ... a computerized peripheral vascular package available in the ... format which allows you to do vascular examinations ... to, while storing patient waveforms and data in ...
Medicine Products: